Arteriosclerosis  >>  CMX-2043  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CMX-2043 / Ischemix
SUPPORT-1, NCT00984802: Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

Checkmark Coronary artery disease
Mar 2013 - Mar 2013: Coronary artery disease
Completed
2a
142
US, RoW
CMX-2043, Placebo control
Ischemix, LLC
Stable Coronary Artery Disease, Percutaneous Coronary Intervention
03/11
04/11

Download Options